Celltrion SkinCure Slightly Increases Stake in Celltrion to 2.18% via Free Share Acquisition

Celltrion SkinCure reported holding 5,079,169 shares of Celltrion as of July 3, 2026, representing a 2.18% stake.
This represents an increase of 241,864 shares from the previous report, driven by a free share acquisition on June 5, 2026, raising the ownership ratio by 0.09 percentage points.
No additional capital outflow occurred due to the free acquisition, and the minimal change in ownership ratio does not materially affect existing shareholder value.
[AI Summary]The 0.09 percentage point increase in Celltrion SkinCure's stake in Celltrion is a technical change from free share acquisition with no dilution or fundraising purpose, neutral to shareholder value. The filer is a de facto controlling shareholder, implying low governance risk.